Industry Resources2019-11-21T14:51:21+00:00

Industry Resources

News & Statements

The Digital Therapeutics Alliance convenes thought leaders from across the industry – including DTx companies, patients, healthcare providers, payers, and industry partners – to establish foundational best practices and frameworks related to DTx product validation, operations, value, and regulatory oversight.

DTA Launches Payer Advisory Group

The Digital Therapeutics Alliance is pleased to launch our Healthcare Payer Advisory Group. We are seeking global engagement from individuals who have experience working within healthcare decision maker and payer settings. Advisory Group members will [...]

Digital Therapeutics Need Quality Standards

Forbes (Greg Licholai) - Quality standards are necessary to help promote adoption of the novel class of interventions called digital therapeutics. This rapidly emerging industry needs to bring together regulators, engineers, practitioners, and companies to [...]

Load More Posts

Industry Insights

Digital therapeutics form an independent category of evidence-based products within the broader digital health landscape. These products are distinguished from other digital health categories by their primary function of delivering software-generated therapeutic interventions directly to patients to prevent, manage, or treat a medical disorder or disease. DTx products will increasingly influence the way healthcare is delivered and consumed across the world.

BIO conference shines a brighter spotlight on digital health

STAT News (Kate Sheridan) -- Leaders like J.P. Morgan’s Jamie Dimon, acting Food and Drug Administration Commissioner Ned Sharpless, and researcher and author Dr. Siddhartha Mukherjee may be the marquee names at the biotech industry’s [...]

Load More Posts

DTx Member Companies in the News

Digital therapeutics present the market with evidence-based technologies that have the ability to elevate medical best practices, address unmet medical needs, expand healthcare access, and improve clinical and health economic outcomes.

Cognoa Launches Pivotal Study of Diagnostic Aid for Autism

Cognoa, a Palo Alto, CA-based pediatric behavioral health company developing digital medicines, announced the launch of a pivotal study of its digital diagnostic aid for autism. The results of this pivotal study will be the basis for the submission to FDA next year. Study of [...]

Better Demonstrates Cost Effectiveness Of Its Digital Therapeutics

Today, we announced the publication of our fifth peer-reviewed study titled Estimating the impact of novel digital therapeutics in type 2 diabetes and hypertension: Health economic analysis. Key findings were presented earlier this year at The International Society for [...]

Sleep Therapy for the Masses May Be Coming to You Soon

CVS Health wants to help millions of American workers improve their sleep. So for the first time, the big pharmacy benefits manager is offering a purely digital therapy as a possible employee benefit. The company [...]

Load More Posts

Stay Up To Date


Sign Up Now